BENEFICIAL EFFECTS OF LIRAGLUTIDE ON ATHEROGENIC SMALL, DENSE LOW-DENSITY LIPOPROTEINS IN PATIENTS WITH TYPE-2 DIABETES: A 2-MONTH PROSPECTIVE PILOT STUDY

被引：0
|
作者：
Nikolic, D. [1 ]
Rizzo, M. [1 ]
Giglio, R. V. [1 ]
Di Bartolo, V. [1 ]
Ferlita, A. [1 ]
Zabbara, A. [1 ]
Tamburello, A. [1 ]
Giannone, V. [1 ]
Montalto, G. [1 ]
Rizvi, A. A. [2 ]
机构：
[1] Univ Palermo, Biomed Dept Internal Med & Med Specialties, Palermo, Italy
[2] Univ S Carolina, Sch Med, Div Endocrinol Diabet & Metab, Columbia, SC USA
来源：
CARDIOLOGY | 2013年 / 126卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：289 / 289
页数：1
相关论文
共 50 条
  • [21] Ipragliflozin lowers small, dense low-density lipoprotein cholesterol levels in Japanese patients with type 2 diabetes mellitus
    Bando, Yukihiro
    Tohyama, Hitomi
    Aoki, Keiko
    Kanehara, Hideo
    Hisada, Azusa
    Okafuji, Kazuhiro
    Toya, Daisyu
    JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY, 2016, 6 : 1 - 7
  • [22] Beneficial effects of liraglutide on adipocytokines, insulin sensitivity parameters and cardiovascular risk biomarkers in patients with Type 2 diabetes: A prospective study
    Diaz-Soto, Gonzalo
    Antonio de Luis, Daniel
    Conde-Vicente, Rosa
    Izaola-Jauregui, Olatz
    Ramos, Carmen
    Romero, Enrique
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 104 (01) : 92 - 96
  • [23] EZITIMIBE ALONE AND IN COMBINATION LOWERS CONCENTRATIONS OF SMALL, DENSE LOW DENSITY LIPOPROTEINS IN TYPE 2 DIABETES MELLITUS
    Winkler, K.
    Jacob, S.
    Schewe, T.
    Putz, G.
    Hoffmann, M. M.
    Konrad, T.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 20 - 21
  • [24] Effect of liraglutide on lipids in patients with type 2 diabetes: a pilot study
    Aoki, Kazutaka
    Kamiyama, Hiroshi
    Takihata, Masahiro
    Taguri, Masataka
    Shibata, Eriko
    Shinoda, Kazuaki
    Yoshii, Taishi
    Nakajima, Shigeru
    Terauchi, Yasuo
    ENDOCRINE JOURNAL, 2020, 67 (09) : 957 - 962
  • [25] Effects of hypolipidemic and hypoglycemic agents on atherogenic small, dense LDL in Type 2 diabetes
    Rizzo, Manfredi
    Tomkin, Gerald H.
    Patti, Angelo Maria
    Pepe, Ilenia
    Valerio, Maria Rosa
    Di Rosa, Salvatore
    Rini, Giovam Battista
    Di Fede, Gaetana
    CLINICAL LIPIDOLOGY, 2011, 6 (05) : 539 - 547
  • [26] Effect of improved glycemic control in patients with type 2 diabetes mellitus on the size of low density lipoproteins, low-density lipoproteins electronegative and the distribution of phospholipase A2 associated with lipoproteins
    Escola Gil, Joan Carles
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2012, 24 (06): : 308 - 309
  • [27] HMG-CoA reductase inhibitor decreases small dense low-density lipoprotein and remnant-like particle cholesterol in patients with type-2 diabetes
    Sone, H
    Takahashi, A
    Shimano, H
    Ishibashi, S
    Yoshino, G
    Morisaki, N
    Saito, Y
    Kawazu, S
    Teramoto, T
    Fujita, T
    Shiba, T
    Iwamoto, Y
    Kuzuya, N
    Akanuma, Y
    Yamada, N
    LIFE SCIENCES, 2002, 71 (20) : 2403 - 2412
  • [28] Higher levels of small dense low-density lipoprotein (LDL) are associated with cardiac autonomic neuropathy in patients with Type 2 diabetes
    Jang, E. -H.
    Park, Y. -M.
    Hur, J.
    Kim, M. -K.
    Ko, S. -H.
    Baek, K. -H.
    Song, K. -H.
    Lee, K. -W.
    Kwon, H. -S.
    DIABETIC MEDICINE, 2013, 30 (06) : 694 - 701
  • [29] Effects of a selective secretory phospholipase A2 inhibitor on low-density lipoproteins in CHD patients with diabetes
    Rosenson, Robert S.
    Hislop, Colin
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (06) : E63 - E63
  • [30] Low-density lipoproteins are more electronegatively charged in type 1 than in type 2 diabetes mellitus
    Gambino, R.
    Pisu, E.
    Pagano, G.
    Cassader, M.
    LIPIDS, 2006, 41 (06) : 529 - 533
12345